Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Long Awaited Carfilzomib Application Submitted To FDA

Home/Supplements/Drugs/Long Awaited Carfilzomib Application Submitted To FDA

Long Awaited Carfilzomib Application Submitted To FDA

This is a perfect example of how sadness and despair can turn to hope in the blink of an eye…

This morning, as I try to wrap my head around my friend Stacey’s death (see previous post), I received an exciting email from Onyx Pharmaceuticals about carfilzomib.  Seems they have officially submitted their application for carfizomib’s approval to the FDA.

What encouraging news!

You can read the official press release by going to my Myeloma News.com site:

BREAKING NEWS:  Onyx Pharmaceuticals submits carfilzomib drug application to FDA.  Requests priority review to speed FDA response

If all goes well, carfilzomib may be approved for use in relapsed/refractory multiple myeloma patients in a matter of months.

While access to this drug may not have saved Stacey, more treatment options like this one might help keep all of us around a while longer…

Feel good and keep smiling!  Pat